NLRP3 inflammasome is involved in many inflammatory and aging diseases, and NLRP3 inhibitor MCC950 has anti-inflammatory and antisenescence effects on some diseases such as Alzheimer's disease. This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.